Publication:
Predominance of influenza A(H3N2) virus genetic subclade 3C.2a1 during an early 2016/17 influenza season in Europe - Contribution of surveillance data from World Health Organization (WHO) European Region to the WHO vaccine composition consultation for northern hemisphere 2017/18

Simple item page
dc.contributor.authorMelidou, Angeliki
dc.contributor.authorBroberg, Eeva K
dc.contributor.authorEuropean region influenza surveillance network
dc.contributor.authorPozo Sanchez, Francisco
dc.contributor.authorCasas Flecha, Inmaculada
dc.contributor.authorLarrauri, Amparo
dc.contributor.authorOliva Dominguez, Jesus Angel
dc.contributor.authorDelgado-Sanz, Concepcion
dc.date.accessioned2023-02-10T11:58:52Z
dc.date.available2023-02-10T11:58:52Z
dc.date.issued2017-09-05
dc.descriptionErratum to "Predominance of influenza A(H3N2) virus genetic subclade 3C.2a1 during an early 2016/17 influenza season in Europe - Contribution of surveillance data from World Health Organization (WHO) European region to the WHO vaccine composition consultation for northern hemisphere 2017/18". Vaccine. 2018 May 3;36(19):2740-2741. doi: 10.1016/j.vaccine.2017.12.039. PMID: 29274700.es_ES
dc.description.abstractDuring the European 2016/17 influenza season, A(H3N2) viruses have predominated and the majority clustered in genetic subclade 3C.2a1. Genetic analyses showed that circulating viruses have undergone considerable genetic diversification of the haemagglutinin gene from the current vaccine virus A/Hong Kong/4801/2014 (clade 3C.2a), but the antigenic data that is limited by the challenges with the antigenic characterisation of currently circulating A(H3N2) viruses, showed no clear evidence of antigenic change. The recommended A(H3N2) vaccine component for the northern hemisphere 2017/18 influenza season remained unchanged. However, early and mid-season vaccine effectiveness (VE) estimates were suggestive of reduced VE against A(H3N2) viruses.es_ES
dc.description.peerreviewedSíes_ES
dc.format.number37es_ES
dc.format.page4828-4835es_ES
dc.format.volume35es_ES
dc.identifier.citationVaccine. 2017 Sep 5;35(37):4828-4835.es_ES
dc.identifier.doi10.1016/j.vaccine.2017.07.057es_ES
dc.identifier.e-issn1873-2518es_ES
dc.identifier.journalVaccinees_ES
dc.identifier.pubmedID28780977es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/15491
dc.language.isoenges_ES
dc.publisherElsevieres_ES
dc.relation.publisherversionhttps://doi.org/10.1016/j.vaccine.2017.07.057es_ES
dc.repisalud.centroISCIII::Centro Nacional de Epidemiologíaes_ES
dc.repisalud.centroISCIII::Centro Nacional de Microbiologíaes_ES
dc.repisalud.institucionISCIIIes_ES
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectA(H3N2)es_ES
dc.subjectAmino acid substitutiones_ES
dc.subjectEmergencees_ES
dc.subjectEuropees_ES
dc.subjectInfluenza viruses_ES
dc.subjectSeasones_ES
dc.subjectSurveillancees_ES
dc.subject.meshEuropees_ES
dc.subject.meshHumanses_ES
dc.subject.meshInfluenza A Virus, H3N2 Subtypees_ES
dc.subject.meshInfluenza Vaccineses_ES
dc.subject.meshInfluenza, Humanes_ES
dc.subject.meshLectinses_ES
dc.subject.meshWorld Health Organizationes_ES
dc.titlePredominance of influenza A(H3N2) virus genetic subclade 3C.2a1 during an early 2016/17 influenza season in Europe - Contribution of surveillance data from World Health Organization (WHO) European Region to the WHO vaccine composition consultation for northern hemisphere 2017/18es_ES
dc.typeresearch articlees_ES
dc.type.hasVersionVoRes_ES
dspace.entity.typePublication
relation.isAuthorOfPublication5611ffc3-de88-4908-b20a-9a15a58c060a
relation.isAuthorOfPublicatione2df6e55-f1d3-423b-a72f-fd9a69cf5915
relation.isAuthorOfPublicatione77e1f2d-b4e2-4ba5-a853-c2795850dcae
relation.isAuthorOfPublicatione5273a7c-5f8e-464e-bea8-d933a72965b7
relation.isAuthorOfPublicatione89a616b-8c7b-43b9-b3df-2a44c45e0765
relation.isAuthorOfPublication.latestForDiscovery5611ffc3-de88-4908-b20a-9a15a58c060a

Files

Original bundle

Now showing 1 - 2 of 2
Thumbnail Image
Name:
PredominanceInfluenzaA_H3N2_Virus_2017.pdf
Size:
1.46 MB
Format:
Adobe Portable Document Format
Description:
Articulo
Download
Thumbnail Image
Name:
Erratum_PredominanceInfluenzaA_H3N2_Virus_2018.pdf
Size:
230.92 KB
Format:
Adobe Portable Document Format
Description:
Correction
Download

Collections

Centro Nacional de Microbiología (CNM)
Centro Nacional de Epidemiología (CNE)